Clinical Trial Update: Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating budesonide for immunosuppression after liver transplantation was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cellular Graft Rejection
• Liver Transplant Rejection

Drugs mentioned

• Budesonide (BUDESONIDE)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Acute Cellular Graft Rejection, Liver Transplant Rejection | Phase 4 | Status: WITHDRAWN